The Centre for Dermatology and Genetic Medicine (DGEM) is situated within the Division of Molecular Medicine (DMM) at the School of Life Sciences complex, University of Dundee. However, both DMM and DGEM are cross-college translational research initiatives that are jointly funded by and very closely linked to Ninewells Medical School.
DGEM has core funding from a £5.9m Wellcome Trust Strategic Award (2012-2017). In addition, DGEM has current research funding in excess of £15m. DGEM is a higher-order multidisciplinary research centre, bringing biologists and clinicians together with physicists, pharmacologists, medicinal chemists and bioinformaticians with the overarching aim of translating our basic science discoveries into new medicines for the treatment of skin disease. DGEM is housed in recently refurbished state-of-the art laboratories as part of a £6m translational medicine infrastructure initiative funded by the University of Dundee.
The School of Life Sciences has about 900 staff and research students. In the 2008 research assessment exercise, Life Sciences in Dundee was ranked 5th in the UK and 1st in Scotland.
Biomedical research at Dundee has a major impact on the local economy by stimulating the regional biotechnology industry which currently accounts for 16% of the local economy. The research outputs also have international impact as a result of collaborations with the world’s major pharmaceutical and biotechnology companies aimed at diseases such as cancer, diabetes, infectious disease, rheumatoid arthritis, and specifically within DGEM, skin disease.
Our research benefits from the wider support structure of the School of Life Sciences and Medicine, Dentistry & Nursing which provide centralised services for the scientific community. This includes specialised core equipment including facilities for proteomics/mass spectrometry, light & electron microscopy, a central facility for biological waste sterilisation and disposal, media preparation, glass washing and sterilisation, DNA sequencing, DNA cloning service, antibody production facility, high-throughput chemical & siRNA library screening, and custom chemical synthesis of small molecules.
DGEM has established a next generation sequencing core facility for the University, known as the Genomic Sequencing Unit (GSU), fully equipped and staffed with leading genomics and bioinformatics expertise. This service is now operational. For further details please refer to the GSU website.